COPD clinical trials in Missouri
10 studies for COPD are looking for participants at sites in Missouri.
Cities in Missouri
Rademikibart IV for Acute Asthma and COPD Exacerbation
- Washington University- Cardiovascular Imaging and Clinical Research Core Laboratory, St Louis
RecruitingPhase 2
Ages 18 to 85 · All sexes · Updated Nov 4, 2026 · NCT07705737To Evaluate the Effect of EXPD-101/FXS7553 Compared With Placebo in Patients With COPD Over 52 Weeks of Treatment
- Hannibal Regional Healthcare System, Inc., Hannibal
RecruitingPhase 2
Ages 40 to 85 · All sexes · Updated Oct 28, 2026 · NCT07684820A Study to Investigate the Effect of AZD6793 in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease
- Research Site, Chesterfield
- Research Site, Hannibal
- Research Site, St Louis
- and 1 more
RecruitingPhase 2
Ages 40 and older · All sexes · Updated Oct 23, 2026 · NCT07082738Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype
- Hannibal Regional Healthcare System- Site Number : 8400035, Hannibal
- Washington University- Site Number : 8400144, St Louis
RecruitingPhase 3
Ages 40 to 80 · All sexes · Updated Oct 23, 2026 · NCT07190222A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate to Severe Chronic Obstructive Pulmonary Disease
- Washington University School of Medicine, St Louis
- Barnes-Jewish Hospital Investigational Drug Service, St Louis
- Barnes-Jewish Hospital, St Louis
- and 2 more
RecruitingPhase 2/3
Ages 35 to 80 · All sexes · Updated Oct 22, 2026 · NCT07363694A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00007)
- Research Site, Hannibal
RecruitingPhase 3
Ages 40 to 80 · All sexes · Updated Oct 9, 2026 · NCT06878261Depemokimab as an Extended Treatment Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation
- GSK Investigational Site, St Louis
RecruitingPhase 3
Ages 40 to 80 · All sexes · Updated Oct 5, 2026 · NCT06959095A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease
- Research Site, St Louis
RecruitingPhase 3
Ages 40 to 80 · All sexes · Updated Oct 2, 2026 · NCT06283966Nebulizer Versus Handheld Maintenance Therapy for Patients With COPD
- Midwest Chest Consultants, P.C., Saint Charles
RecruitingPhase 4
Ages 60 and older · All sexes · Updated Sep 14, 2026 · NCT07816835A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00006)
- Research Site, St Louis
RecruitingPhase 3
Ages 40 to 80 · All sexes · Updated Sep 3, 2026 · NCT06883305From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.